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A number of metabolic changes within the liver occur concurrent with hepatic regener-
ation. These processes suggest that the administration of an antiestrogen might alter the 
rate of hepatic regeneration. To examine this question, male Wistar rats were treated with 
tamoxifen (0.1 mglratlday or 1.0 mglratlday) or vehicle for three days prior to and after 
partial hepatectomy, and the anatomic and biochemical process of hepatic regeneration 
was assessed. Tamoxifen administration caused a dose-dependent decrease in the hepatic 
cytosolic estrogen receptor activity and, conversely, a dose-dependent increase in 
cytosolic androgen receptor activity. Despite these changes in baseline hepatic sex steroid 
receptor status. all receptor activities were comparable between the three groups within 
24 hr of partial hepatectomy. Moreover. no differences in any of the the parameters 
assessing hepatic regeneration following partial hepatectomy were evident: liver-body 
ratio, ornithine decarboxylase activity, and thymidine kinase activity. This lack of effect 
of tamoxlfen treatment on hepatic regeneration suggests either that estrogens do not play 
a role in the modulation of liver growth after partial hepatectomy or that. once initiated. 
the regenerath'e process per se determines a series of e\'ents that regulate hepatocellular 
sex hormone receptor status independent of extrahepatic stimuli. 
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It is established that the mammalian liver has recep-
tors for both androgens (1) and estrogens (2) and 
that it has a number of sexually dimorphic charac-
teristics (3, 4). Recently it has been shown that 
during the initial period of hepatic regeneration 
following two-thirds partial hepatectomy, male rat 
liver loses many of its male-specific attributes, 
including a temporary disappearance of its cytosolic 
androgen receptor content (5). Although the role of 
hepatic "demasculinization" during regeneration is 
as yet uncertain. it suggests that agents that either 
attenuate or accelerate the loss of hepatic sexual 
dimorphic characteristics or the sex hormone status 
of the liver might be able to alter either the rate or 
degree of hepatic regeneration. 
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To evaluate the effect of hepatic estrogen recep-
tor modulation in the regulation of hepatic regener-
ation. male rats were pretreated with the triphenyl-
ethylene antiestrogen tamoxifen {(Z)-2-[P-(l.2-
diphenyl-I-butenyl)-phenoxy]-N,N-di methylethyl-
amine} for three days prior to and daily after a 
standard two-thirds partial hepatectomy. The sub-
sequent hepatic regenerative response was assessed 
with respect to liver growth and the induction of 
polyamine and DNA synthetic pathways. In addi-
tion, both androgen and estrogen receptor activities 
in hepatic cytosol were measured to investigate the 
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sex hormone receptor status of the liver during 
regeneration. The liver's expression of androgenic 
activity was assessed also by quantitating the alco-
hol dehydrogenase activity within the liver, as the 
degradation of this enzyme is known to be acceler-
ated by the presence of androgens (6). 
MATERIALS AND METHODS 
Animals and Supplies. Adult male inbred Wistar rats 
(200-350 g) were purchased from Harlan Sprague Dawley 
(Indianapolis, Indiana). Tamoxifen citrate, manufactured 
by Stuart Pharmaceuticals (Wilmington, Delaware), was 
obtained from the Presbyterian University Hospital phar-
macy. New England Nuclear (Boston, Massachusetts) 
was the source for the [14C]ornithine (57.6 mCilmmol), 
[lH]estradiol (99 Cilmmol), [3H]R1881 (87 Cilmmol), and 
unlabeled R 1881 utilized in these experiments. The tritiat-
ed thymidine (5 Cilmmol) and ACS scintillation fluid used 
were from Amersham (Arlington Heights, Illinois). The 
absolute ethanol and DEAE-<:ellulose paper were from 
U.S. Industrial Chemicals Co. (Tuscola, Illinois) and 
BioRad (Richmond, California), respectively. Unlabeled 
ornithine, pyridoxal phosphate, Tris base, diethylstilbe-
strol, adenosine triphosphate, sodium molybdate, nicoti-
namide adenine dinucleotide, and bovine serum albumin 
were obtained from Sigma Chemical Co. (St. Louis, 
Missouri). All other chemicals were from Fisher Chemi-
cal Co. (Pittsburgh, Pennsylvania). 
AnimaJ Treatment and Tissue Preparation. Male Wistar 
rats were assigned randomly to the various treatment 
groups. Animals in the tamoxifen-treated groups were 
given either 0.1 mg or I mg tamoxifen dissolved in a 
vehicle consisting of 0.2 ml peanut oil-acetone (9: I) 
administered subcutaneously beginning 72 hr prior to 
partial hepatectomy and every 24 hr thereafter until the 
time of sacrifice. Animals used as placebo controls re-
ceived 0.2 ml of the identical vehicle administered sub-
cutaneously using the same dosing schedule. A two-thirds 
partial hepatectomy was performed under light ether 
anesthesia as described by Higgins and Anderson be-
tween 9:00 and 12:00 AM (7). The liver tissue removed at 
the time of hepatectomy was used to differentiate be-
tween the initial effects of the drug and the effects of 
surgery for the parameters assessed. 
At various times up to 72 hr after hepatectomy, animals 
from the vehicle control group and the two tamoxifen-
treated groups were anesthetized with ether and weighed. 
The liver remnant was removed, weighed, and homoge-
nized in 4 vol of ice-cold buffer consisting of 0.25 M 
sucrose, 1.5 mM EDTA, 10 mM me rcaptoethanol , 150 
I-LM leupeptin, 1 mM benzamidine, and 10 mM Tris HCI 
(PH 7.4) using a Brinkman Polytron homogenizer. Cyto-
sol was prepared by centrifugation at 103,000 g for 1 hr at 
40 C. All cytosolic enzyme assays were performed imme-
diately after preparation of the cytosol. 
Sex Steroid Receptor Assays. The activity of the cyto-
solie estrogen receptors was determined by measuring the 
specific binding of a saturating concentration of fH]estra-
diol (6). 
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The cytosolic androgen receptor assay used was similar 
in design to that described for the cytosolic estrogen 
receptor assay (5). Tritiated R 1881, a synthetic androgen, 
was used as the labeled ligand and unlabeled RI881 was 
used in the nonspecific binding assays. Triamcinolone 
acetonide (S I-LM) was included in all androgen assays to 
block binding to the glucocorticoid receptor. 
Ornithine De<:arboxylase Assay. Ornithine decarboxyl-
ase activity was determined by measuring the 14C01 
released from labelled ornithine (9). 
Thymidine Kinase Assay. Thymidine kinase activity 
was determined by measuring the in vitro conversion of 
thymidine to thymidine phosphate (10). 
Alcobol Debydrogenase Assay. Alcohol dehydrogenase 
activity was measured spectrophotometrically at 340 nm 
at ambient temperature by measuring NADH production 
in a I-ml reaction mixture consisting of cytosol, 2.8 mM 
nicotinamide adenine dinucleotide, and 18 mM ethanol in 
100 mM Tris HCI buffer (pH 7.2) (II). 
Miscellaneous Methods and Procedures. Protein concen-
trations were determined by the method of Lowry et aI 
(12) with bovine serum albumin used as the standard. 
Statistical analysis of the data was performed using 
one-way ANOVA followed by Scheffe's test through the 
Abstat program on an IBM PC-XT. A P value of 0.05 or 
less was considered to be a significant. All results are 
presented as mean values ± SEM. 
RESULTS 
Tamoxifen administration for three days caused a 
significant, dose-dependent reduction in the hepatic 
cytosolic estrogen receptor activity prior to partial 
hepatectomy (Figure 1). During the first 6 hr follow-
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Fie I. Effect of tamoxifen treatment and partial hepatectomy on 
hepatic cytosolic estrogen receptor activity. Male rats were 
treated subcutaneously (or three days prior to and daily after 
partial hepatectomy with vehicle or tamoxi(en. Animals were 
sacrificed at the times noted, and the hepatic cytosolic estrogen 
receptor activity was determined in femtomoles of specific 
estrogen bound per milligram cytosolic protein. Bars represent 
means ~ SEM for three to (our animals per group. • P < 0.05 vs 
vehicle-treated controls; up < 0.01 vs vehicle-treated controls. 
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r-Ig 2. Effect of tamoxifen treatment and partial hepatectomy on 
hepatic cytosolic androgen receptor activity. Male rats were 
treated as described in Figure I. Cytosolic androgen receptor 
activity is reported as femtomoles of androgen bound per milli-
gram cytosolic protein. Bars represent means ± SEM for three to 
four animals per group . • p < 0.05 vs vehicle,treated controls. 
ing surgery, the hepatic estrogen receptor activity 
in the livers from the 0.1 mglday-treated animals 
and the vehicle-treated controls decreased further 
such that there was no difference among the three 
groups. At 48 hr posthepatectomy, the hepatic 
estrogen receptor content of the control animals 
had recovered to a level comparable to that present 
prior to surgery. In contrast, the hepatic estrogen 
receptor activity of the animals receiving tamoxifen 
continued to be markedly reduced through 72 hr. 
The results of study of the androgen receptor 
activity present in the livers of each group at each 
time point are shown in Figure 2. Prior to hepatec-
tomy, tamoxifen administration caused a dose-
dependent twofold increase in androgen receptor 
activity in the I mglday-treated animals. Partial 
hepatectomy produced a significant reduction in the 
androgen receptor activity within 6 hr in the control 
and 0.1 mglday-treated animals. This reduction in 
androgen receptor activity following partial hepa-
tectomy was delayed in the animals receiving the 
higher dose of tamoxifen. At 24-72 hr after partial 
hepatectomy, the androgen receptor in all three 
groups was reduced but comparable. At 72 hr 
following surgery, the androgen receptor activity in 
all three groups was 30% or less of that measured at 
the time of the partial hepatectomy for each group. 
As shown in Figure 3, the administration of tam-
oxifen, at either dose examined, had no effect on 
alcohol dehydrogenase activity prior to hepatec-
tomy. However. a transient increase in enzyme 
aigtDpliv~ Diuasrs afld Scit!flt:t!. Vol. )4. No. I (January 1989) 
I 
I 
Alcohol Dehydrogenase ActiVity 
Effect of q~xlfen 
C"..::JVehde 
'.-------------------, 
Trre Al1er ~teetomy torsi 
Fig 3. Effect of tamoxifen treatment and partial hepatectomy on 
hepatic alcohol dehydrogenase activity. Data are reported as 
milliunits alcohol dehydrogenase activity per milligram cy\osolic 
protein. The bars represent means ± SEt.! for three to four 
animals per ,roup . • p < 0.05 vs vehicle,treated controls. "P < 
0.01 vs vehicle·treated controls. 
activity was evident in the two tamoxifen-treated 
groups at 48 hr after surgery. 
Despite the changes in the cytosolic steroid re-
ceptor activities following tamoxifen administra-
tion, the rate of hepatic growth after two-thirds 
partial hepatectomy. presented in Figure 4, was not 
affected. Between 6 and 72 hr following hepatec-
tomy, there was a twofold increase in the Iiver-
body ratio in both the tamoxifen-treated animals 
and the vehicle-treated controls. There was no 
difference in the liver-body ratio among the three 
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Fig 4. Effect of tamoxifen treatment on the rate of liver growth 
after partial hepatectomy in male rats. Data are reported as a 
ratio of the liver weight to the body weight at the indicated times 
and are means ± SEM for three to four animals per group. 
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Fig S. Effect of tamoxifen treatment on the induction of hepatic 
ornithine decarboxylase activity following partial hepatectomy. 
Data are presented as counts per minute f~CMO released per hour 
per milligram cytosolic protein at the time of hepatectomy 
(baseline) and 6 hr thereafter (peak). Bars represent means :t 
SEM for three to four animals per group. 
groups of animals at any time point examined. 
Furthermore, there was no difference in the protein 
concentrations of the liver remnants removed at the 
various time points among the controls and the 
tamoxifen-treated groups (data not shown), indicat-
ing that any hepatic edema or steatosis occurring 
during the regenerative process was comparable in 
all three groups. 
Because an increase in polyamine synthesis has 
been shown to be an important aspect of the initia-
tion of hepatic regeneration (13), the effects of 
tamoxifen treatment on the activity of hepatic orni-
thine decarboxylase, the rate-limiting factor in poly-
amine synthesis, was assessed. Prior to hepatectomy, 
tamoxifen administration had no effect on ornitrune 
decarboxylase activity (Figure 5, baseline). Partial 
hepatectomy caused a significant increase in enzyme 
activity within the liver in all three groups (Figure 5, 
peak) 6 hr after surgery, the time that maximal induc-
tion of the enzyme activity has been shown to occur 
(9, 13). There was no difference in the extent of 
induction among the three groups. 
During hepatic regeneration, an increase in DNA 
synthesis, initiated by an increase in hepatic thymi-
dine kinase activity, occurs. Tamoxifen pretreat-
ment had no effect on thymidine kinase activity 
prior to or following partial hepatectomy (Figure 6, 
time zero). Induction of enzyme activity induced by 
partial hepatectomy peaked at 48 hr at similar levels 
of activity in all three groups. No difference among 
the tamoxifen-treated and vehicle-treated animals 
with respect to the time of peak activity or the level 
of activity at any time point assessed was found. 
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Fig 6. Effect of tamoxifen treatment on hepatic thymidine kinase 
activity induced by partial hepatectomy in male rats. Data are 
presented as disintegrations per minute thymidine phosphate 
produced per minute per milligram cytosolic protein and are 
reported as means :t SEM for three to four animals per group. 
DISCUSSION 
Male liver has been shown to lose many of its 
male-specific characteristics during the process of 
hepatic regeneration that follows partial hepatec-
tomy (5). The present study was designed to exam-
ine whether the antiestrogen tamoxifen would inter-
fere with the regenerative process and alter the rate 
or extent of the resultant hepatic regeneration. In 
these experiments, male rats were treated for three 
days prior to partial hepatectomy with either tamox-
ifen or the vehicle used to solubilize the drug and 
then subjected to a standard two-thirds partial hep-
atectomy. 
Previously published data support the hypothesis 
that estrogens and antiestrogens may playa role in 
the initiation of hepatic regeneration (5). Moreover 
estrogens have been shown to act as promoters of 
neoplasia in rats (14). Thus an increased incidence 
of hepatomas has been reported in women using 
oral contraceptives (15). Estrogen administration 
also has been shown to induce increases in liver 
mass, thymidine kinase activity, mitotic index, and 
[3H]thymidine incorporation into DNA (16, 17). 
Conversely, chronic tamoxifen administration re-
sults in a reduction in liver mass, although the Iiver-
body ratio is not altered. 
The role of estrogens in hepatic regeneration after 
partial hepatectomy has been incompletely investi-
gated to date. Partial hepatectomy leads to an 
increase in serum estradiol levels and hepatic estro-
gen receptor content in untreated male rats (5). 
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Experiments on treatment with exogenous estro-
gens, however, have given conflicting results. In a 
study by Mukundan and Bamji (17), administration 
of the combination of ethynyl estradiol and estra-
diol diacetate, two drugs found in oral contracep-
tives, to female rats was shown to inhibit liver 
growth during the first 24 hr following partial hep-
atectomy and to delay the expected increase in 
eH]thymidine incorporation into DNA. In contrast, 
Fisher et al (16) have reported that female rats 
treated with 1713-estradiol achieve greater liver 
weights seven days after hepatectomy than do ve-
hicle-treated controls. It is difficult to compare 
directly the results of these two experiments be-
cause of the many differences between the studies, 
including age of the rats at the time of hepatectomy, 
the strain of rat used, the type of estrogen used, the 
duration of treatment prior to hepatectomy, and the 
parameters that were assessed after hepatectomy. 
Even less information is available on the effect of 
antiestrogens on hepatic regeneration. Chronic ad-
ministration of a low dose of tamoxifen to male rats 
has been shown by one group of investigators to 
have no effect on liver growth following partial 
hepatectomy (18). Furthermore, these same inves-
tigators found that the acute administration of a 
higher dose of tamoxifen also had no effect on liver 
growth, although they observed a delay in the 
expected increase in the mitotic index following 
tamoxifen treatment (18). 
The present study extends these earlier studies 
with respect to the sex of the rat used, the dosage 
range of drug examined, and the number of param-
eters assessed, including sex steroid receptor activ-
ity (18). Another difference between the present 
study and the earlier study is the use of hepatic 
thymidine kinase activity as a measure of DNA 
synthesis rather than the mitotic index. The vari-
ance for thymidine kinase activity is less than that 
for the mitotic index, and a good correlation be-
tween the two measures has been established by 
several investigators (l0). 
In the present study, treatment with tamoxifen at 
two different doses a full log unit apart had no effect 
on the rate of liver growth observed after partial 
hepatectomy. The similar levels of hepatic ornithine 
decarboxylase activity in treated and control ani-
mals further supports the lack of an effect of tamox-
ifen on hepatic regeneration: Moreover, the time 
course and peak levels of DNA synthesis stimulated 
by hepatectomy and assessed by thymidine kinase 
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activity measurements were not different between 
the three treatment groups. 
The observed lack of effect of tamoxifen or 
hepatic regeneration cannot be attributed to some 
inability of the drug to interact with the sex hor-
mone receptor systems within the liver. In the 
present study, tamoxifen administration, prior to 
partial hepatectomy, caused a dose-dependent de-
crease in the hepatic cytosolic estrogen receptor 
activity. This finding is consistent with prior reports 
in which antiestrogen treatment reduced hepatic 
cytosolic estrogen receptor content, presumably by 
interfering with receptor cycling (19). Tamoxifen 
also alters androgen-sensitive systems and, in the 
present study, produced a dose-dependent increase 
in hepatic cytosolic androgen receptor activity prior 
to hepatectomy and a transient increase in the 
activity of the androgen-sensitive enzyme alcohol 
dehydrogenase 48 hr following surgery. 
Interestingly, within 24 hr after the initiation of 
hepatic regeneration, all tamoxifen-induced 
changes in the activities of both sex steroid recep-
tors were abolished. One explanation for this obser-
vation is that tamoxifen might not have been con-
verted to its more active 4-hydroxytamoxifen 
derivative, as well as several other metabolites of 
the drug by hepatic microsomal enzymes (20), be-
cause partial hepatectomy is known to produce an 
obligate reduction in the liver's microsomal mixed 
function oxidase activity. This would have reduced 
its effective biologic activity below a threshold level 
required for an effect upon regeneration to have 
been observed. The fact that the doses oftamoxifen 
used ranged over a full log unit makes this possibil-
ity less likely. however. 
Alternatively, endogenous regulatory factors as-
sociated with hepatic regeneration may be more 
potent than tamoxifen in the modulation of sex 
hormone receptor activity within the liver, although 
a mechanism by which regeneration might control 
sex hormone receptor activity is not yet known. 
Another possibility is that a putative humoral 
growth-stimulating factor(s) though to be released 
from regenerating liver (21, 22) might modulate 
hepatic sex steroid receptor activity. Yet another 
possibility is that these same growth factors might 
interact with extrahepatic regulatory systems such 
as the hypothalamic-pituitary axis (23, 24), which 
then modulates both the regenerative process and 
the hepatic content of sex hormone receptors. The 
data from the present studies do not allow us to 
discriminate among these various hypotheses. 
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In summary, the results of the present study 
demonstrate that antiestrogens interact with the 
hepatic sex steroid receptor systems, and, despite 
the chariges in cytosolic androgen and estrogen 
receptor activity caused by tamoxifen preadininis-
tration, no change in the hepatic regenerative re-
sponse to a two-thirds partial hepatectomy was 
observed in male rats. 
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